2017 National Conference on Infection Control

NCIC 2017 (4)

The Nigerian Infection Control association (NICA) is organizing her 2017  Scientific Conference with the theme: INTEGRATING INFECTION PREVENTION CONTROL INTO HEALTHCARE DELIVERY: A NATIONAL PRIORITY”.
This conference will hold from 23rd – 25th November, 2017 in Abuja, Nigeria.
This is a call for abstracts for presentation at the conference.


More here

Posted in Uncategorized | Leave a comment

2016 National Conference on Infection Control



The Nigerian Infection Control association (NICA) is organizing her 2016  Scientific Conference with the theme: “BREAKING THE CHAIN OF TRANSMISSION: INFECTION CONTROL AND EPIDEMICS”.

This conference will hold from 17th – 18th November, 2016 in Abuja, Nigeria.

The Pre-conference workshops on Basics of Infection Prevention and Control and Healthcare waste management will hold on the 16th of November 2016 for participants who register for this.

This is a call for abstracts for presentation at the conference.

More here

Posted in Uncategorized | Leave a comment

Conference Report on Stimulating Innovation, Sustainable Use and Global Access to Antibiotics

On 2 June, 2016, the DRIVE-AB consortium, with support from the EU Presidency of the Netherlands, held a high-level conference on stimulating innovation, sustainable use and global access to antibiotics in Amsterdam. The event attracted more than 180 policy makers, regulatory and public health experts and economists to identify and evaluate reward models that are feasible, practical and can be implemented globally.

Discussions among the experts identified key gaps in global action and policy, mechanisms for ensuring sustainable use and new economic models to stimulate antibiotic innovation while ensuring access and sustainable use. The full conference report outlines the key messages and outcomes from these discussions in more detail.

The conference was followed on 3 June by an invitation-only workshop for key stakeholders to explore the feasibility of DRIVE-AB’s five preliminary reward models, which are now being re-evaluated in the context of the feedback received. A short report detailing the outcomes of this workshop will be available soon.

The full conference report detailing the discussions and outputs of this important meeting is now available: please click here to view the report.

A shorter conference summary is also available here.

Posted in Uncategorized | Leave a comment

The Deadly Ebola Virus


The reality of the Ebola outbreak that hit the Republic of Guinea months ago has now hit our dear nation, Nigeria.

As Infection Prevention and Control Health Practitioners, much lies in our hand to control this deadly outbreak. We need to be armed to make the right decisions.

The Ebola outbreak in Nigeria has come at a distressful time as this when the nation is experiencing a lot of insecurity challenges. Every sector is stressed, even the health sector.

As you really try to battle hard this deadly virus, reading up and knowing what is right to be done, we at Nigerian Infection Control Association (NICA) have found out these resources that will aid you in your battle against this disease.

Key facts

  • Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans.
  • EVD outbreaks have a case fatality rate of up to 90%.
  • EVD outbreaks occur primarily in remote villages in Central and West Africa, near tropical rainforests.
  • The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.
  • Fruit bats of thePteropodidae family are considered to be the natural host of the Ebola virus.
  • Severely ill patients require intensive supportive care. No licensed specific treatment or vaccine is available for use in people or animals.


Ebola first appeared in 1976 in 2 simultaneous outbreaks, in Nzara, Sudan, and in Yambuku, Democratic Republic of Congo. The latter was in a village situated near the Ebola River, from which the disease takes its name.

Genus Ebolavirus is 1 of 3 members of the Filoviridae family (filovirus), along with genus Marburgvirus and genus Cuevavirus. Genus Ebolavirus comprises 5 distinct species:

  • Bundibugyo ebolavirus (BDBV)
  • Zaire ebolavirus (EBOV)
  • Reston ebolavirus (RESTV)
  • Sudan ebolavirus (SUDV)
  • Taï Forest ebolavirus (TAFV).


BDBV, EBOV, and SUDV have been associated with large EVD outbreaks in Africa, whereas RESTV and TAFV have not. The RESTV species, found in Philippines and the People’s Republic of China, can infect humans, but no illness or death in humans from this species has been reported to date.


Ebola is introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals. In Africa, infection has been documented through the handling of infected chimpanzees, gorillas, fruit bats, monkeys, forest antelope and porcupines found ill or dead or in the rainforest.



Ebola then spreads in the community through human-to-human transmission, with infection resulting from direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and indirect contact with environments contaminated with such fluids. Burial ceremonies in which mourners have direct contact with the body of the deceased person can also play a role in the transmission of Ebola. Men who have recovered from the disease can still transmit the virus through their semen for up to 7 weeks after recovery from illness.

Health-care workers have frequently been infected while treating patients with suspected or confirmed EVD. This has occurred through close contact with patients when infection control precautions are not strictly practiced.

Among workers in contact with monkeys or pigs infected with Reston ebolavirus, several infections have been documented in people who were clinically asymptomatic. Thus, RESTV appears less capable of causing disease in humans than other Ebola species.


However, the only available evidence available comes from healthy adult males. It would be premature to extrapolate the health effects of the virus to all population groups, such as immuno-compromised persons, persons with underlying medical conditions, pregnant women and children. More studies of RESTV are needed before definitive conclusions can be drawn about the pathogenicity and virulence of this virus in humans.


Signs and symptoms

EVD is a severe acute viral illness often characterized by the sudden onset of fever, intense weakness, muscle pain, headache and sore throat. This is followed by vomiting, diarrhoea, rash, impaired kidney and liver function, and in some cases, both internal and external bleeding. Laboratory findings include low white blood cell and platelet counts and elevated liver enzymes.


People are infectious as long as their blood and secretions contain the virus. Ebola virus was isolated from semen 61 days after onset of illness in a man who was infected in a laboratory.

The incubation period, that is, the time interval from infection with the virus to onset of symptoms, is 2 to 21 days.



Other diseases that should be ruled out before a diagnosis of EVD can be made include: malaria, typhoid fever, shigellosis, cholera, leptospirosis, plague, rickettsiosis, relapsing fever, meningitis, hepatitis and other viral haemorrhagic fevers.

Ebola virus infections can be diagnosed definitively in a laboratory through several types of tests:

  • antibody-capture enzyme-linked immunosorbent assay (ELISA)
  • antigen detection tests
  • serum neutralization test
  • reverse transcriptase polymerase chain reaction (RT-PCR) assay
  • electron microscopy
  • virus isolation by cell culture.

Samples from patients are an extreme biohazard risk; testing should be conducted under maximum biological containment conditions.

Vaccine and treatment

No licensed vaccine for EVD is available. Several vaccines are being tested, but none are available for clinical use.

Severely ill patients require intensive supportive care. Patients are frequently dehydrated and require oral rehydration with solutions containing electrolytes or intravenous fluids.

No specific treatment is available. New drug therapies are being evaluated.

Natural host of Ebola virus

In Africa, fruit bats, particularly species of the genera Hypsignathus monstrosus, Epomops franqueti and Myonycteris torquata, are considered possible natural hosts for Ebola virus. As a result, the geographic distribution of Ebolaviruses may overlap with the range of the fruit bats.


Prevention and control

Controlling Reston ebolavirus in domestic animals

No animal vaccine against RESTV is available. Routine cleaning and disinfection of pig or monkey farms (with sodium hypochlorite or other detergents) should be effective in inactivating the virus.



If an outbreak is suspected, the premises should be quarantined immediately. Culling of infected animals, with close supervision of burial or incineration of carcasses, may be necessary to reduce the risk of animal-to-human transmission. Restricting or banning the movement of animals from infected farms to other areas can reduce the spread of the disease.


As RESTV outbreaks in pigs and monkeys have preceded human infections, the establishment of an active animal health surveillance system to detect new cases is essential in providing early warning for veterinary and human public health authorities.

Reducing the risk of Ebola infection in people

In the absence of effective treatment and a human vaccine, raising awareness of the risk factors for Ebola infection and the protective measures individuals can take is the only way to reduce human infection and death.

In Africa, during EVD outbreaks, educational public health messages for risk reduction should focus on several factors:

  • Reducing the risk of wildlife-to-human transmission from contact with infected fruit bats or monkeys/apes and the consumption of their raw meat.
  • Animals should be handled with gloves and other appropriate protective clothing.
  • Animal products (blood and meat) should be thoroughly cooked before consumption.
  • Reducing the risk of human-to-human transmission in the community arising from direct or close contact with infected patients, particularly with their bodily fluids.
  • Close physical contact with Ebola patients should be avoided.
  • Gloves and appropriate personal protective equipment should be worn when taking care of ill patients at home.
  • Regular hand washing is required after visiting patients in hospital, as well as after taking care of patients at home.
  • Communities affected by Ebola should inform the population about the nature of the disease and about outbreak containment measures, including burial of the dead.
  • People who have died from Ebola should be promptly and safely buried.


Pig farms in Africa can play a role in the amplification of infection because of the presence of fruit bats on these farms. Appropriate biosecurity measures should be in place to limit transmission. For RESTV, educational public health messages should focus on reducing the risk of pig-to-human transmission as a result of unsafe animal husbandry and slaughtering practices, and unsafe consumption of fresh blood, raw milk or animal tissue. Gloves and other appropriate protective clothing should be worn when handling sick animals or their tissues and when slaughtering animals. In regions where RESTV has been reported in pigs, all animal products (blood, meat and milk) should be thoroughly cooked before eating.

Controlling infection in health-care settings

Human-to-human transmission of the Ebola virus is primarily associated with direct or indirect contact with blood and body fluids. Transmission to health-care workers has been reported when appropriate infection control measures have not been observed.

It is not always possible to identify patients with EBV early because initial symptoms may be non-specific. For this reason, it is important that health-care workers apply standard precautions consistently with all patients – regardless of their diagnosis – in all work practices at all times. These include basic hand hygiene, respiratory hygiene, the use of personal protective equipment (according to the risk of splashes or other contact with infected materials), safe injection practices and safe burial practices.

Health-care workers caring for patients with suspected or confirmed Ebola virus should apply, in addition to standard precautions, other infection control measures to avoid any exposure to the patient’s blood and body fluids and direct unprotected contact with the possibly contaminated environment. When in close contact (within 1 metre) of patients with EBV, health-care workers should wear face protection (a face shield or a medical mask and goggles), a clean, non-sterile long-sleeved gown, and gloves (sterile gloves for some procedures).

Laboratory workers are also at risk. Samples taken from suspected human and animal Ebola cases for diagnosis should be handled by trained staff and processed in suitably equipped laboratories.

Standard precautions are recommended in the care and treatment of all patients regardless of their perceived or confirmed infectious status. They include the basic level of infection control—hand hygiene, use of personal protective equipment to avoid direct contact with blood and body fluids, prevention of needle stick and injuries from other sharp instruments, and a set of environmental controls.


Posted in Uncategorized | Tagged , , , , , , | Leave a comment

Distance Learning Course on Antimicrobial Stewardship


DLC Course for AMS


  • To increase the basic knowledge needed to improve infection prevention and control (IPC) practices and the judicious use of antimicrobial agents amongst healthcare workers.
  • To improve management and use of antimicrobials (ATM) for prevalent infectious diseases at a hospital healthcare facility level
  • To reduce ATM-related adverse events and contain the emergence and spread of bacterial resistance
  • To encourage the formation of Antimicrobial Stewardship (AMS) teams made up of doctors and nurses



Physicians, clinical pharmacists, clinical microbiologists and nurses from all African Countries who are already involved in, or are interested in developing antimicrobial stewardship and IPC activities.



The BASIC ISC/ICAN training distance learning course will be entirely developed online using the moodle platform.



Certificate will be awarded by ISC/ICAN to a candidate who participates for a total of 85 hours.





COURSE RUNS FROM September 2014 through December 2014.


For more information, download this document Distance-learning-course-in-Antimicrobial-Stewardhip-for-Africa

Posted in Uncategorized | 3 Comments

We are back


Yes, we are back and we apologize for the long silence that we have had over time.

We appreciate your kind patience and we promise to bring you the best this year. The NICA Team is poised to bring you even more timely and relevant information and also keep you updated with the latest happenings in the world of Infection Control.

You can expect to see regular updates on NICA activities as well as more interactions and participation in various International Associations. As it has been our practice, we also will regularly update you on the latest practices as regards infection control as well as bring you all the current and latest fact sheets on various infectious diseases and on Healthcare Associated Infections.

This year, we encourage you as much as possible to partake in activities that will broaden your knowledge base and increase competence especially as regards Infection Control Practices.

We will bring to your notice, workshops, conferences and seminars (local & international).

The NICA email (infonica.ng@gmail.com, nicanigeria@gmail.com) would also be used to aid prompt and efficient dissemination of information. So please, regularly check your e-mail.

Please be reminded that our annual dues for 2014 are due.  Visit our Become a member link for more information on registration and subscription. It is our duty as members of the association to promptly pay our dues. Encouraging other people with interest in Infection Control to register with the association is highly solicited.

Below is the Account Detail
Bank Name: Union Bank of Nigeria Plc
Account Number: 0007461632

Finally, take some time to visit our May 5  SAVE LIVES: Clean Your Hands Global Campaign link and also have an infection-free year.


Posted in Uncategorized | Leave a comment


Happy new year!!! Welcome 2011! The new year has started and with it the opportunity to have a better year than the last. This year, NICA is poised to bring you more, to bring you timely and relevant information and keep you up to date with the latest happenings in the world of infection control.

This year we are going to post regular updates on NICA activities. There will also be more interactions and participation in various international associations. We will be regularly updated on the latest practices as regards infection control as well as bring you all the current/ latest fact sheets on various infectious diseases and on healthcare associated infections.

There is a new NICA email group to aid prompt and efficient dissemination of information.

In this new year, we are all encouraged as much as possible to partake in activities that will broaden our knowledge base and increase our competence especially as regards infection control practices. We will be bringing to your notice workshops, confrences and seminars (local & international) as they come up.

Plans are underway for a National Symposium on HandWashing, Health and Development.
The theme is ‘Making Big Differences through Small Actions:Meeting the Health MDGs through Hand Washing and Improved Hygiene in Nigeria.’

Please be reminded that our annual dues for 2011 are due. It is our duty as members of the association to pay our dues promptly as at when due. New members are welcome!

Lastly, We are all encouraged to participate in the ongoing voters registration exercise. If you have not registered please take time out to do so. It is your civic responsibility.Your vote is your voice!

Once again, welcome to 2011!

Posted in Uncategorized | Leave a comment

NICA’s One-day Workshop

The Nigeria Infection Control Association had a One-day Workshop on Wednesday, the 30th of June 2010. Venue was the Sickle Cell Centre, Opposite Lagos teaching Hospital, Idi Araba, Lagos. The Theme was Infection Control ‘The Time is Now’.

The programme of events included:

Welcome Remarks by the Chairman of NICA, Professor Tolu Odugbemi

A speech by the Special Guest of Honor – The Honorable Commissioner of Health, Lagos state Dr. Jide Idris. Though absent, he was ably represented by Dr. H.A Abdul-Razaq.

The Chairman of the Medical Advisory Committee of LUTH, Dr. M.O. Ogunlewe was also  present representing the Chief Medical Director.

Speakers at the event included:

“Infection Control as a Quality Standard” – Dr. A. Adewakun

“Injection Safety and Waste Management” – Dr. Lami Jibowu

“Prevention of Needle stick Injuries” – Dr Eric Ossei of Becton Dicson West Africa

“Prevention of Surgical Site Infections” – Dr. Adenike Olayinka of Ahmadu Bello University, Zaria

“Preventing TB Transmission in the workplace; Issues of Airborne Control” – Prof F.T. Ogunsola, Head of Medical Microbiology, CMUL

“Risk of Transmission of Infections in the dental setting” – Dr. Sofola of the Faculty of Dentistry, CMUL

There was tea breaks and lunch and exhibitions from Corporate Bodies like AstraZeneca, Swipha Industries etc. Participants went home with generous gift packs of the products of these companies.

We wish to use this opportunity to say THANK YOU to all who contributed to the success of this workshop; especially our dear sponsors:











Did you attend the Workshop? What did you enjoy most about it?

Posted in Uncategorized | 2 Comments

Photos from the Infection Control Workshop

Posted in Uncategorized | Leave a comment